To assess the frequency of occurrence of the three in-frame kinase fusions (CPQ-PRKDC, VGLL4-PRKG1, CAPZA2-MET) in clinical samples, we conducted RT-PCR and Sanger sequencing for 122 primary endometrial cancer tissues. The gene discussed is MET; the disease is endometrial cancer.